OncoTherapy Science (TSE:4564) Inventories, Raw Materials & Components: 円39.7 Mil (As of Mar. 2026)


TSE:4564 OncoTherapy Science Inc TSE:4564
50 GF Score
Price 円21.00
GF Value 円17.04
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is OncoTherapy Science Inventories, Raw Materials & Components?

OncoTherapy Science TSE:4564 +5.00% 50 Inventories, Raw Materials & Components is 円39.7 Mil as of Mar. 2026. GuruFocus rates TSE:4564 with a GF Score™ of 50/100 and a GF Value™ of 円17.04 (Modestly Overvalued). The stock has 1 warning sign investors should review.

OncoTherapy Science's inventories, raw materials & components for the quarter that ended in Mar. 2026 was 円39.7 Mil.

OncoTherapy Science's quarterly raw materials increased from Mar. 2025 (円32.8 Mil) to Sep. 2025 (円61.5 Mil) but then declined from Sep. 2025 (円61.5 Mil) to Mar. 2026 (円39.7 Mil).

OncoTherapy Science's annual raw materials declined from Mar. 2024 (円43.8 Mil) to Mar. 2025 (円32.8 Mil) but then increased from Mar. 2025 (円32.8 Mil) to Mar. 2026 (円39.7 Mil).

OncoTherapy Science Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for OncoTherapy Science's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoTherapy Science Inventories, Raw Materials & Components Chart

OncoTherapy Science Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 123.10 52.35 43.78 32.76 39.66

OncoTherapy Science Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.78 65.29 32.76 61.54 39.66
TSE:4564
50GF Score
OncoTherapy Science Inc TSE:4564
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OncoTherapy Science Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of 円39.7 Mil mean?
OncoTherapy Science (TSE:4564) has a Inventories, Raw Materials & Components of 円39.7 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on OncoTherapy Science and its competitors.
Is OncoTherapy Science's Inventories, Raw Materials & Components too high?
OncoTherapy Science's current Inventories, Raw Materials & Components is 円39.7 Mil. Overall, OncoTherapy Science has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OncoTherapy Science's Inventories, Raw Materials & Components compare to VRTX and REGN?
OncoTherapy Science's Inventories, Raw Materials & Components of 円39.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on OncoTherapy Science and its competitors. OncoTherapy Science's current Inventories, Raw Materials & Components is 円39.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoTherapy Science stock overvalued right now?
Based on GuruFocus' analysis, OncoTherapy Science (TSE:4564) is currently considered Modestly Overvalued. The stock's GF Value™ is 円17.04, compared to a current price of 円21.00 — trading 23.2% above its estimated fair value. The current Inventories, Raw Materials & Components is 円39.7 Mil. OncoTherapy Science's overall GF Score™ is 50/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For OncoTherapy Science (TSE:4564), the current Inventories, Raw Materials & Components is 円39.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OncoTherapy Science (TSE:4564) Overvalued in 2026?

Based on GuruFocus' analysis, OncoTherapy Science stock appears to be overvalued. The current stock price of 円21.00 is trading 23.2% above its estimated GF Value™ of 円17.04. GuruFocus considers OncoTherapy Science to be Modestly Overvalued.

Key valuation signals for TSE:4564:

  • Inventories, Raw Materials & Components: 円39.7 Mil
  • GF Value™: 円17.04 vs. price of 円21.00 (23.2% above fair value)
  • GF Score™: 50/100 with 1 warning sign

No single metric tells the full story. See the TSE:4564 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OncoTherapy Science Business Description

Other Exchanges 30O:Germany
Address 11th Floor, Kanagawa Science Park R&D, 3-2-1 Sakado, Kanagawa, Kawasaki, JPN, 213-0012
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.
50GF Score

Get the complete analysis for TSE:4564

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円21.00
Price
円17.04
GF Value